AbbVie Inc. (ABBV)'s Pipeline Advances with Temab-A and ABBV-706, Shares Flat
AbbVie Inc. (NYSE:ABBV) has spotlighted major advancements in its oncology pipeline at the ASCO 2025 Annual Meeting, unveiling promising clinical data for its next-generation antibody-drug conjugates (ADCs), Temab-A and ABBV-706. Temab-A, a c-Met-targeting ADC, achieved a 63% objective response rate in pre-treated EGFR-mutated non-small cell lung cancer (NSCLC) patients, with over half maintaining their response for at least six months, demonstrating efficacy across c-Met expression levels and supporting further clinical exploration.
A doctor utilizing a cloud-based healthcare platform to access patient records.
ABBV-706, which targets SEZ6, delivered a 61% confirmed response rate in second-line or later small cell lung cancer (SCLC), outperforming existing therapies in cross-trial comparisons, while also showing activity in high-grade neuroendocrine neoplasms. Both therapies utilize AbbVie Inc. (NYSE:ABBV)'s proprietary Top1i payload to induce targeted cancer cell death, reinforcing the company's commitment to addressing difficult-to-treat tumors.
Despite these clinical milestones, AbbVie Inc. (NYSE:ABBV)'s stock price remained steady at around $187.15, mirroring broader market stability as investors await key financial updates. With a consensus price target of $210.68, analysts see an 11% upside, highlighting ABBV's robust long-term performance and future revenue potential as its innovative pipeline matures.
While we acknowledge the potential of ABBV to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ABBV and that has 100x upside potential, check out our report about this
READ NEXT: and
Disclosure: None.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNET
22 minutes ago
- CNET
Charge Laptops and More on the Go with $70 off This 250W Anker Power Bank
There are plenty of power banks that can recharge your phone when you're on the go. But what about a tablet or even your laptop? This Anker Prime power bank boasts a substantial capacity so it can handle even larger devices, and right now you can pick it up at a pretty incredible price. Woot currently has this advanced Anker power bank on sale for $110, which saves you a generous $70 compared to the usual list price. This deal is available through June 3, but there's no guarantee that it won't sell out before then. We'd recommend you don't wait too long if you're hoping to take advantage of these savings. This device is only about the size of a soda can, which makes it pretty easy to throw in your bag. It comes with two USB-C ports and a USB-A port so that you can charge multiple devices at once. If you download the Anker app, you'll be able to get sound alerts to locate your power bank when you misplace it and get real-time stats on your charger (the built-in display also provides these stats when in use). Hey, did you know? CNET Deals texts are free, easy and save you money. You can even take this device on a flight since it falls just below the TSA carry-on limit of 100-watt hours. With such a high capacity, this power bank is good for phones, tablets and even laptops. Why this deal matters Anker has claimed over half the spots on our list of the best power banks for 2025, so its chargers are some of the absolute best out there at the moment. This Prime model is one of the most substantial banks in its lineup, and has a massive 27,650-mAh capacity and 250W output so it can handle larger devices like laptops and tablets. And it's a pretty serious bargain now that you can grab it for $70 off.
Associated Press
23 minutes ago
- Associated Press
Veeva to Present at Upcoming Investor Conferences
PLEASANTON, Calif., May 30, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced participation in the following investor conferences: The above presentations will be webcast. Links to the live and archived webcast will be available on Veeva's investor relations website at About Veeva Systems Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit Veeva uses its website as a means of disclosing material non-public information, announcing upcoming investor conferences, and for complying with its disclosure obligations under Regulation FD. Accordingly, you should monitor Veeva's investor relations website in addition to following its press releases, SEC filings, and public conference calls and webcasts. Investor Relations Contact: Gunnar Hansen Veeva Systems Inc. 267-460-5839 [email protected] Media Contact: Maria Scurry Veeva Systems Inc. 781-366-7617 [email protected] | View original content: SOURCE Veeva Systems
Yahoo
24 minutes ago
- Yahoo
Veeva to Present at Upcoming Investor Conferences
PLEASANTON, Calif., May 30, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced participation in the following investor conferences: Baird 2025 Global Consumer, Technology & Services Conference, New York, NY. Paul Shawah, EVP Strategy, is presenting on Tuesday, June 3, 2025, at 10:50 a.m. Eastern Time. William Blair 45th Annual Growth Stock Conference, Chicago, IL. Brian Van Wagener, CFO, is presenting on Wednesday, June 4, 2025, at 1:20 p.m. Central Time. The above presentations will be webcast. Links to the live and archived webcast will be available on Veeva's investor relations website at About Veeva SystemsVeeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit Veeva uses its website as a means of disclosing material non-public information, announcing upcoming investor conferences, and for complying with its disclosure obligations under Regulation FD. Accordingly, you should monitor Veeva's investor relations website in addition to following its press releases, SEC filings, and public conference calls and webcasts. Investor Relations Contact: Gunnar HansenVeeva Systems Inc.267-460-5839ir@ Media Contact:Maria ScurryVeeva Systems Inc.781-366-7617pr@ View original content: SOURCE Veeva Systems
